- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
In the non-oncology precision medicine market, the application of molecular biology is to study the etiology of diseases other than cancer at the molecular level, so target-based therapy or individualized therapy can be used to cure patients' health-related problems.
According to our latest study, the global Non-Oncology Precision Medicine market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Non-Oncology Precision Medicine market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Non-Oncology Precision Medicine market size and forecasts, in consumption value ($ Million), 2018-2029
Global Non-Oncology Precision Medicine market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Non-Oncology Precision Medicine market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Non-Oncology Precision Medicine market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Non-Oncology Precision Medicine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Non-Oncology Precision Medicine market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott Laboratories, Agilent Technologies, Inc., Asuragen, Inc., Almac Group and AstraZeneca PLC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Non-Oncology Precision Medicine market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Applied Sciences
Precision Diagnostics
Digital Health and Information Technology
Precision Therapeutics
Market segment by Application
Infectious Diseases
Neurology
Cardiovascular
Lifestyle and Endocrinology
Gastroenterology
Others
Market segment by players, this report covers
Abbott Laboratories
Agilent Technologies, Inc.
Asuragen, Inc.
Almac Group
AstraZeneca PLC
Bristol Myers Squibb
bioMérieux SA.
BGI
Danaher Corp.
Illumina, Inc.
Invitae Corporation
Opko Health, Inc.
Teva Pharmaceutical Industries Ltd.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Non-Oncology Precision Medicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Non-Oncology Precision Medicine, with revenue, gross margin and global market share of Non-Oncology Precision Medicine from 2018 to 2023.
Chapter 3, the Non-Oncology Precision Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Non-Oncology Precision Medicine market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Non-Oncology Precision Medicine.
Chapter 13, to describe Non-Oncology Precision Medicine research findings and conclusion.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Non-Oncology Precision Medicine
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Non-Oncology Precision Medicine by Type
1.3.1 Overview: Global Non-Oncology Precision Medicine Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Non-Oncology Precision Medicine Consumption Value Market Share by Type in 2022
1.3.3 Applied Sciences
1.3.4 Precision Diagnostics
1.3.5 Digital Health and Information Technology
1.3.6 Precision Therapeutics
1.4 Global Non-Oncology Precision Medicine Market by Application
1.4.1 Overview: Global Non-Oncology Precision Medicine Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Infectious Diseases
1.4.3 Neurology
1.4.4 Cardiovascular
1.4.5 Lifestyle and Endocrinology
1.4.6 Gastroenterology
1.4.7 Others
1.5 Global Non-Oncology Precision Medicine Market Size & Forecast
1.6 Global Non-Oncology Precision Medicine Market Size and Forecast by Region
1.6.1 Global Non-Oncology Precision Medicine Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Non-Oncology Precision Medicine Market Size by Region, (2018-2029)
1.6.3 North America Non-Oncology Precision Medicine Market Size and Prospect (2018-2029)
1.6.4 Europe Non-Oncology Precision Medicine Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Non-Oncology Precision Medicine Market Size and Prospect (2018-2029)
1.6.6 South America Non-Oncology Precision Medicine Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Non-Oncology Precision Medicine Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Non-Oncology Precision Medicine Product and Solutions
2.1.4 Abbott Laboratories Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Agilent Technologies, Inc.
2.2.1 Agilent Technologies, Inc. Details
2.2.2 Agilent Technologies, Inc. Major Business
2.2.3 Agilent Technologies, Inc. Non-Oncology Precision Medicine Product and Solutions
2.2.4 Agilent Technologies, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Agilent Technologies, Inc. Recent Developments and Future Plans
2.3 Asuragen, Inc.
2.3.1 Asuragen, Inc. Details
2.3.2 Asuragen, Inc. Major Business
2.3.3 Asuragen, Inc. Non-Oncology Precision Medicine Product and Solutions
2.3.4 Asuragen, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Asuragen, Inc. Recent Developments and Future Plans
2.4 Almac Group
2.4.1 Almac Group Details
2.4.2 Almac Group Major Business
2.4.3 Almac Group Non-Oncology Precision Medicine Product and Solutions
2.4.4 Almac Group Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Almac Group Recent Developments and Future Plans
2.5 AstraZeneca PLC
2.5.1 AstraZeneca PLC Details
2.5.2 AstraZeneca PLC Major Business
2.5.3 AstraZeneca PLC Non-Oncology Precision Medicine Product and Solutions
2.5.4 AstraZeneca PLC Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AstraZeneca PLC Recent Developments and Future Plans
2.6 Bristol Myers Squibb
2.6.1 Bristol Myers Squibb Details
2.6.2 Bristol Myers Squibb Major Business
2.6.3 Bristol Myers Squibb Non-Oncology Precision Medicine Product and Solutions
2.6.4 Bristol Myers Squibb Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bristol Myers Squibb Recent Developments and Future Plans
2.7 bioMérieux SA.
2.7.1 bioMérieux SA. Details
2.7.2 bioMérieux SA. Major Business
2.7.3 bioMérieux SA. Non-Oncology Precision Medicine Product and Solutions
2.7.4 bioMérieux SA. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 bioMérieux SA. Recent Developments and Future Plans
2.8 BGI
2.8.1 BGI Details
2.8.2 BGI Major Business
2.8.3 BGI Non-Oncology Precision Medicine Product and Solutions
2.8.4 BGI Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 BGI Recent Developments and Future Plans
2.9 Danaher Corp.
2.9.1 Danaher Corp. Details
2.9.2 Danaher Corp. Major Business
2.9.3 Danaher Corp. Non-Oncology Precision Medicine Product and Solutions
2.9.4 Danaher Corp. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Danaher Corp. Recent Developments and Future Plans
2.10 Illumina, Inc.
2.10.1 Illumina, Inc. Details
2.10.2 Illumina, Inc. Major Business
2.10.3 Illumina, Inc. Non-Oncology Precision Medicine Product and Solutions
2.10.4 Illumina, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Illumina, Inc. Recent Developments and Future Plans
2.11 Invitae Corporation
2.11.1 Invitae Corporation Details
2.11.2 Invitae Corporation Major Business
2.11.3 Invitae Corporation Non-Oncology Precision Medicine Product and Solutions
2.11.4 Invitae Corporation Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Invitae Corporation Recent Developments and Future Plans
2.12 Opko Health, Inc.
2.12.1 Opko Health, Inc. Details
2.12.2 Opko Health, Inc. Major Business
2.12.3 Opko Health, Inc. Non-Oncology Precision Medicine Product and Solutions
2.12.4 Opko Health, Inc. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Opko Health, Inc. Recent Developments and Future Plans
2.13 Teva Pharmaceutical Industries Ltd.
2.13.1 Teva Pharmaceutical Industries Ltd. Details
2.13.2 Teva Pharmaceutical Industries Ltd. Major Business
2.13.3 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product and Solutions
2.13.4 Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Non-Oncology Precision Medicine Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Non-Oncology Precision Medicine by Company Revenue
3.2.2 Top 3 Non-Oncology Precision Medicine Players Market Share in 2022
3.2.3 Top 6 Non-Oncology Precision Medicine Players Market Share in 2022
3.3 Non-Oncology Precision Medicine Market: Overall Company Footprint Analysis
3.3.1 Non-Oncology Precision Medicine Market: Region Footprint
3.3.2 Non-Oncology Precision Medicine Market: Company Product Type Footprint
3.3.3 Non-Oncology Precision Medicine Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Non-Oncology Precision Medicine Consumption Value and Market Share by Type (2018-2023)
4.2 Global Non-Oncology Precision Medicine Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Non-Oncology Precision Medicine Consumption Value Market Share by Application (2018-2023)
5.2 Global Non-Oncology Precision Medicine Market Forecast by Application (2024-2029)
6 North America
6.1 North America Non-Oncology Precision Medicine Consumption Value by Type (2018-2029)
6.2 North America Non-Oncology Precision Medicine Consumption Value by Application (2018-2029)
6.3 North America Non-Oncology Precision Medicine Market Size by Country
6.3.1 North America Non-Oncology Precision Medicine Consumption Value by Country (2018-2029)
6.3.2 United States Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
6.3.3 Canada Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
6.3.4 Mexico Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Non-Oncology Precision Medicine Consumption Value by Type (2018-2029)
7.2 Europe Non-Oncology Precision Medicine Consumption Value by Application (2018-2029)
7.3 Europe Non-Oncology Precision Medicine Market Size by Country
7.3.1 Europe Non-Oncology Precision Medicine Consumption Value by Country (2018-2029)
7.3.2 Germany Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
7.3.3 France Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
7.3.5 Russia Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
7.3.6 Italy Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Non-Oncology Precision Medicine Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Non-Oncology Precision Medicine Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Non-Oncology Precision Medicine Market Size by Region
8.3.1 Asia-Pacific Non-Oncology Precision Medicine Consumption Value by Region (2018-2029)
8.3.2 China Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.3 Japan Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.4 South Korea Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.5 India Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
8.3.7 Australia Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
9 South America
9.1 South America Non-Oncology Precision Medicine Consumption Value by Type (2018-2029)
9.2 South America Non-Oncology Precision Medicine Consumption Value by Application (2018-2029)
9.3 South America Non-Oncology Precision Medicine Market Size by Country
9.3.1 South America Non-Oncology Precision Medicine Consumption Value by Country (2018-2029)
9.3.2 Brazil Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
9.3.3 Argentina Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Non-Oncology Precision Medicine Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Non-Oncology Precision Medicine Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Non-Oncology Precision Medicine Market Size by Country
10.3.1 Middle East & Africa Non-Oncology Precision Medicine Consumption Value by Country (2018-2029)
10.3.2 Turkey Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
10.3.4 UAE Non-Oncology Precision Medicine Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Non-Oncology Precision Medicine Market Drivers
11.2 Non-Oncology Precision Medicine Market Restraints
11.3 Non-Oncology Precision Medicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Non-Oncology Precision Medicine Industry Chain
12.2 Non-Oncology Precision Medicine Upstream Analysis
12.3 Non-Oncology Precision Medicine Midstream Analysis
12.4 Non-Oncology Precision Medicine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Non-Oncology Precision Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Non-Oncology Precision Medicine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Non-Oncology Precision Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Non-Oncology Precision Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Abbott Laboratories Company Information, Head Office, and Major Competitors
Table 6. Abbott Laboratories Major Business
Table 7. Abbott Laboratories Non-Oncology Precision Medicine Product and Solutions
Table 8. Abbott Laboratories Non-Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Abbott Laboratories Recent Developments and Future Plans
Table 10. Agilent Technologies, Inc. Company Information, Head Office, and Major Competitors
Table 11. Agilent Technologies, Inc. Major Business
Table 12. Agilent Technologies, Inc. Non-Oncology Precision Medicine Product and Solutions
Table 13. Agilent Technologies, Inc. Non-Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Agilent Technologies, Inc. Recent Developments and Future Plans
Table 15. Asuragen, Inc. Company Information, Head Office, and Major Competitors
Table 16. Asuragen, Inc. Major Business
Table 17. Asuragen, Inc. Non-Oncology Precision Medicine Product and Solutions
Table 18. Asuragen, Inc. Non-Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Asuragen, Inc. Recent Developments and Future Plans
Table 20. Almac Group Company Information, Head Office, and Major Competitors
Table 21. Almac Group Major Business
Table 22. Almac Group Non-Oncology Precision Medicine Product and Solutions
Table 23. Almac Group Non-Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Almac Group Recent Developments and Future Plans
Table 25. AstraZeneca PLC Company Information, Head Office, and Major Competitors
Table 26. AstraZeneca PLC Major Business
Table 27. AstraZeneca PLC Non-Oncology Precision Medicine Product and Solutions
Table 28. AstraZeneca PLC Non-Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. AstraZeneca PLC Recent Developments and Future Plans
Table 30. Bristol Myers Squibb Company Information, Head Office, and Major Competitors
Table 31. Bristol Myers Squibb Major Business
Table 32. Bristol Myers Squibb Non-Oncology Precision Medicine Product and Solutions
Table 33. Bristol Myers Squibb Non-Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bristol Myers Squibb Recent Developments and Future Plans
Table 35. bioMérieux SA. Company Information, Head Office, and Major Competitors
Table 36. bioMérieux SA. Major Business
Table 37. bioMérieux SA. Non-Oncology Precision Medicine Product and Solutions
Table 38. bioMérieux SA. Non-Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. bioMérieux SA. Recent Developments and Future Plans
Table 40. BGI Company Information, Head Office, and Major Competitors
Table 41. BGI Major Business
Table 42. BGI Non-Oncology Precision Medicine Product and Solutions
Table 43. BGI Non-Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. BGI Recent Developments and Future Plans
Table 45. Danaher Corp. Company Information, Head Office, and Major Competitors
Table 46. Danaher Corp. Major Business
Table 47. Danaher Corp. Non-Oncology Precision Medicine Product and Solutions
Table 48. Danaher Corp. Non-Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Danaher Corp. Recent Developments and Future Plans
Table 50. Illumina, Inc. Company Information, Head Office, and Major Competitors
Table 51. Illumina, Inc. Major Business
Table 52. Illumina, Inc. Non-Oncology Precision Medicine Product and Solutions
Table 53. Illumina, Inc. Non-Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Illumina, Inc. Recent Developments and Future Plans
Table 55. Invitae Corporation Company Information, Head Office, and Major Competitors
Table 56. Invitae Corporation Major Business
Table 57. Invitae Corporation Non-Oncology Precision Medicine Product and Solutions
Table 58. Invitae Corporation Non-Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Invitae Corporation Recent Developments and Future Plans
Table 60. Opko Health, Inc. Company Information, Head Office, and Major Competitors
Table 61. Opko Health, Inc. Major Business
Table 62. Opko Health, Inc. Non-Oncology Precision Medicine Product and Solutions
Table 63. Opko Health, Inc. Non-Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Opko Health, Inc. Recent Developments and Future Plans
Table 65. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 66. Teva Pharmaceutical Industries Ltd. Major Business
Table 67. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Product and Solutions
Table 68. Teva Pharmaceutical Industries Ltd. Non-Oncology Precision Medicine Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 70. Global Non-Oncology Precision Medicine Revenue (USD Million) by Players (2018-2023)
Table 71. Global Non-Oncology Precision Medicine Revenue Share by Players (2018-2023)
Table 72. Breakdown of Non-Oncology Precision Medicine by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Non-Oncology Precision Medicine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Non-Oncology Precision Medicine Players
Table 75. Non-Oncology Precision Medicine Market: Company Product Type Footprint
Table 76. Non-Oncology Precision Medicine Market: Company Product Application Footprint
Table 77. Non-Oncology Precision Medicine New Market Entrants and Barriers to Market Entry
Table 78. Non-Oncology Precision Medicine Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Non-Oncology Precision Medicine Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Non-Oncology Precision Medicine Consumption Value Share by Type (2018-2023)
Table 81. Global Non-Oncology Precision Medicine Consumption Value Forecast by Type (2024-2029)
Table 82. Global Non-Oncology Precision Medicine Consumption Value by Application (2018-2023)
Table 83. Global Non-Oncology Precision Medicine Consumption Value Forecast by Application (2024-2029)
Table 84. North America Non-Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Non-Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Non-Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Non-Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Non-Oncology Precision Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Non-Oncology Precision Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Non-Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Non-Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Non-Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Non-Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Non-Oncology Precision Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Non-Oncology Precision Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Non-Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Non-Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Non-Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Non-Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Non-Oncology Precision Medicine Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Non-Oncology Precision Medicine Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Non-Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Non-Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Non-Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Non-Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Non-Oncology Precision Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Non-Oncology Precision Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Non-Oncology Precision Medicine Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Non-Oncology Precision Medicine Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Non-Oncology Precision Medicine Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Non-Oncology Precision Medicine Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Non-Oncology Precision Medicine Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Non-Oncology Precision Medicine Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Non-Oncology Precision Medicine Raw Material
Table 115. Key Suppliers of Non-Oncology Precision Medicine Raw Materials
List of Figures
Figure 1. Non-Oncology Precision Medicine Picture
Figure 2. Global Non-Oncology Precision Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Non-Oncology Precision Medicine Consumption Value Market Share by Type in 2022
Figure 4. Applied Sciences
Figure 5. Precision Diagnostics
Figure 6. Digital Health and Information Technology
Figure 7. Precision Therapeutics
Figure 8. Global Non-Oncology Precision Medicine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Non-Oncology Precision Medicine Consumption Value Market Share by Application in 2022
Figure 10. Infectious Diseases Picture
Figure 11. Neurology Picture
Figure 12. Cardiovascular Picture
Figure 13. Lifestyle and Endocrinology Picture
Figure 14. Gastroenterology Picture
Figure 15. Others Picture
Figure 16. Global Non-Oncology Precision Medicine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 17. Global Non-Oncology Precision Medicine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 18. Global Market Non-Oncology Precision Medicine Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 19. Global Non-Oncology Precision Medicine Consumption Value Market Share by Region (2018-2029)
Figure 20. Global Non-Oncology Precision Medicine Consumption Value Market Share by Region in 2022
Figure 21. North America Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East and Africa Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Non-Oncology Precision Medicine Revenue Share by Players in 2022
Figure 27. Non-Oncology Precision Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 28. Global Top 3 Players Non-Oncology Precision Medicine Market Share in 2022
Figure 29. Global Top 6 Players Non-Oncology Precision Medicine Market Share in 2022
Figure 30. Global Non-Oncology Precision Medicine Consumption Value Share by Type (2018-2023)
Figure 31. Global Non-Oncology Precision Medicine Market Share Forecast by Type (2024-2029)
Figure 32. Global Non-Oncology Precision Medicine Consumption Value Share by Application (2018-2023)
Figure 33. Global Non-Oncology Precision Medicine Market Share Forecast by Application (2024-2029)
Figure 34. North America Non-Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 35. North America Non-Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 36. North America Non-Oncology Precision Medicine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 38. Canada Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 39. Mexico Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 40. Europe Non-Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 41. Europe Non-Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 42. Europe Non-Oncology Precision Medicine Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 44. France Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 45. United Kingdom Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 46. Russia Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 47. Italy Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Non-Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Non-Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Non-Oncology Precision Medicine Consumption Value Market Share by Region (2018-2029)
Figure 51. China Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 52. Japan Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 53. South Korea Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 54. India Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 55. Southeast Asia Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 56. Australia Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 57. South America Non-Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 58. South America Non-Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 59. South America Non-Oncology Precision Medicine Consumption Value Market Share by Country (2018-2029)
Figure 60. Brazil Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 61. Argentina Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 62. Middle East and Africa Non-Oncology Precision Medicine Consumption Value Market Share by Type (2018-2029)
Figure 63. Middle East and Africa Non-Oncology Precision Medicine Consumption Value Market Share by Application (2018-2029)
Figure 64. Middle East and Africa Non-Oncology Precision Medicine Consumption Value Market Share by Country (2018-2029)
Figure 65. Turkey Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 66. Saudi Arabia Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 67. UAE Non-Oncology Precision Medicine Consumption Value (2018-2029) & (USD Million)
Figure 68. Non-Oncology Precision Medicine Market Drivers
Figure 69. Non-Oncology Precision Medicine Market Restraints
Figure 70. Non-Oncology Precision Medicine Market Trends
Figure 71. Porters Five Forces Analysis
Figure 72. Manufacturing Cost Structure Analysis of Non-Oncology Precision Medicine in 2022
Figure 73. Manufacturing Process Analysis of Non-Oncology Precision Medicine
Figure 74. Non-Oncology Precision Medicine Industrial Chain
Figure 75. Methodology
Figure 76. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
